![]()
|
||
|
||
![]()
|
||
| This study published in the peer-reviewed
journal "Spine" reported on 1,419 patients and introduced, for the first time, the
existence and importance of
genomic spine disorders. Juvenile
discogenic disease (JDD) was the particular genomic entity reported on
because of its unique appearance on MRI studies. Following the publication
of this study it has
become apparent that JDD is but one part of a genomic spine disorder
spectrum. It is now estimated, with better imaging and with better awareness on the
part of clinicians, that as many as 50% of all patients presenting with
significant back complaints have an underlying genomic spine disorder. Unless identified and
effectively addressed by appropriate
preventive programs those with these problems are at high risk for
significant
disability later in life. It has been estimated, by some spine surgeons, that
about 80% of patients coming to surgery (frequently multiple surgeries)
have previously unrecognized and untreated underlying genomic disorders.
The Editor's experience confirms this observation. |
||
|
||
|
Heithoff, who has published numerous radiologic survey studies, was one of the first to recognize that JDD, as a congenital abnormality of development which was frequently seen in association with other congenital abnormalities (the "Zebra Phenomenon" principle). |
||
|
By physicians becoming more aware of these "zebra" associations they
can then better appreciate the radiologic clues
which then allow the diagnosis
of genomic spine disorders to become identifiable. In 1997 Heithoff's associates noted that "Early recognition with prompt institution of conservative therapy and vocational counseling may be important in these patients to avoid, or at least delay, the complications of degenerative disc disease" (Gundry C, Fritts H: Juvenile Discogenic Disease, Clin. Ortho. Rel. Res., Number 343, 1997). |
||
|
|